Damià Barceló

Dr. Damià Barceló

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2006 in Talanta
Verified
Journal Article
Closed access
MHM Hernando
M Hernando
MMM Mezcua
M Mezcua
AFA Fernandezalba
A Fernandezalba
DBDamià Barceló
Damià Barceló


1 January 2011 in Water Research
Verified
Journal Article
Closed access
AJAleksandra Jelic
Aleksandra Jelic
Meritxell GrosMeritxell Gros
Meritxell Gros
AGAntoni Ginbreda
Antoni Ginbreda
RCRaquel Cespedes-Sánchez
Raquel Cespedes-Sánchez
FVFrancesc Ventura
Francesc Ventura
DBDamià Barceló
Damià Barceló

1 March 2020 in Science of The Total Environment
Verified
Journal Article
Closed access
YFYufan Fei
Yufan Fei
SHShunyin Huang
Shunyin Huang
HZHaibo Zhang
Haibo Zhang
YTYazhi Tong
Yazhi Tong
DWDishi Wen
Dishi Wen
DBDamià Barceló
Damià Barceló

1 September 2013 in Environment International
Verified
Journal Article
Open access
FPFrancisca Pérez
Francisca Pérez
Martí NadalMartí Nadal
Martí Nadal
ANAlícia Navarro-Ortega
Alícia Navarro-Ortega
FFFrancesc Fàbrega
Francesc Fàbrega
Jose L DomingoJose L Domingo
Jose L Domingo
MFMarinella Farré
Marinella Farré
Perfluoroalkyl substances (PFASs) are environmental pollutants with an important bioaccumulation potential. However, their metabolism and distribution in humans are not well studied. In this study, the concentrations of 21 PFASs were analyzed in 99 samples of autopsy tissues (brain, liver, lung, bone, and kidney) from subjects who had been living in Tarragona (Catalonia, Spain). The samples were analyzed by solvent extraction and online purification by turbulent flow and liquid chromatography coupled to tandem mass spectrometry. The occurrence of PFASs was confirmed in all human tissues. Although PFASs accumulation followed particular trends depending on the specific tissue, some similarities were found. In kidney and lung, perfluorobutanoic acid was the most frequent compound, and at highest concentrations (median values: 263 and 807ng/g in kidney and lung, respectively). In liver and brain, perfluorohexanoic acid showed the maximum levels (median: 68.3 and 141ng/g, respectively), while perfluorooctanoic acid was the most contributively in bone (median: 20.9ng/g). Lung tissues accumulated the highest concentration of PFASs. However, perfluorooctane sulfonic acid and perfluorooctanoic acid were more prevalent in liver and bone, respectively. To the best of our knowledge, the accumulation of different PFASs in samples of various human tissues from the same subjects is here reported for the very first time. The current results may be of high importance for the validation of physiologically based pharmacokinetic models, which are being developed for humans. However, further studies on the distribution of the same compounds in the human body are still required.

1 April 2020 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
BZBianying Zhou
Bianying Zhou
JWJiaqing Wang
Jiaqing Wang
HZHaibo Zhang
Haibo Zhang
HSHuahong Shi
Huahong Shi
YFYufan Fei
Yufan Fei
DBDamià Barceló
Damià Barceló